Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
about
Interacting partners of FEN1 and its role in the development of anticancer therapeutics.FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner.Effect of FAM196B in human lung adenocarcinoma.
P2860
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@en
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@nl
type
label
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@en
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@nl
prefLabel
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@en
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@nl
P2093
P2860
P1433
P1476
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
@en
P2093
Binghui Shen
Chandra Sekhar Kathera
Feng Jiang
Haoyan Chen
Hongfang Sun
Hongzhi Li
Lingfeng He
P2860
P356
10.1016/J.EBIOM.2016.11.012
P577
2016-11-10T00:00:00Z